statistiche ricercatore

Continente	#
NA - Nord America	762
EU - Europa	480
AS - Asia	418
SA - Sud America	45
Continente sconosciuto - Info sul continente non disponibili	13
AF - Africa	11
OC - Oceania	7
Totale	1.736

Nazione	#
US - Stati Uniti d'America	733
RU - Federazione Russa	176
CN - Cina	120
IT - Italia	114
SG - Singapore	109
HK - Hong Kong	50
IE - Irlanda	37
KR - Corea	35
BR - Brasile	33
FR - Francia	27
SE - Svezia	27
VN - Vietnam	26
IN - India	24
DE - Germania	22
FI - Finlandia	17
CA - Canada	16
CH - Svizzera	13
GB - Regno Unito	13
JP - Giappone	10
NL - Olanda	9
BD - Bangladesh	8
AU - Australia	6
JO - Giordania	6
MX - Messico	6
EC - Ecuador	5
TW - Taiwan	5
UA - Ucraina	5
PL - Polonia	4
SA - Arabia Saudita	4
AR - Argentina	3
ID - Indonesia	3
IQ - Iraq	3
IR - Iran	3
MA - Marocco	3
NO - Norvegia	3
NP - Nepal	3
SK - Slovacchia (Repubblica Slovacca)	3
ZA - Sudafrica	3
AT - Austria	2
BA - Bosnia-Erzegovina	2
CR - Costa Rica	2
DO - Repubblica Dominicana	2
EG - Egitto	2
LT - Lituania	2
PY - Paraguay	2
TH - Thailandia	2
AE - Emirati Arabi Uniti	1
BJ - Benin	1
CG - Congo	1
CO - Colombia	1
CZ - Repubblica Ceca	1
ES - Italia	1
GR - Grecia	1
JM - Giamaica	1
KG - Kirghizistan	1
LB - Libano	1
LV - Lettonia	1
MM - Myanmar	1
NG - Nigeria	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
TR - Turchia	1
UZ - Uzbekistan	1
Totale	1.723

Nome	#
Efficacy, Long-term Efficacy and Tolerability of Lacosamide, Stiripentol, Fenfluramine Hydrochloride and Levetiracetam in children, adolescents and young adults with different types of epilepsy	344
Multiple genomic copy number variants associated with periventricular nodular heterotopia indicate extreme genetic heterogeneity	191
Efficacy and Safety of Long-Term Treatment with Stiripentol in Children and Adults with Drug-Resistant Epilepsies: A Retrospective Cohort Study of 196 Patients	167
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009))	162
Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study	155
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17458 subjects	148
Polygenic burden in focal and generalized epilepsies	144
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals	143
Whole exome sequencing in a cohort of 48 trios with neurodevelopmental disorders	136
Fenfluramine treatment for Dravet syndrome: Long term real-world analysis demonstrates safety and reduced health care burden	122
Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study	24
Totale	1.736

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	43	0	0	0	5	0	5	0	1	12	3	7	10
2022/2023	152	10	28	10	4	0	31	26	9	13	2	6	13
2023/2024	103	1	9	13	4	4	10	7	23	0	10	13	9
2024/2025	634	24	64	38	69	178	103	11	41	19	31	32	24
2025/2026	606	77	81	66	38	71	22	64	20	36	37	25	69
2026/2027	139	15	12	75	37	0	0	0	0	0	0	0	0
Totale													1.736